Advertisement
Advertisement
Cochlear Limited (CHEOY)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
At close: 03:46PM EDT
Advertisement
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 68.18 |
| Open | 68.18 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 67.63 - 69.06 |
| 52 Week Range | 63.18 - 94.21 |
| Volume | |
| Avg. Volume | 10,288 |
| Market Cap | 9.085B |
| Beta (5Y Monthly) | 0.26 |
| PE Ratio (TTM) | 50.78 |
| EPS (TTM) | 1.36 |
| Earnings Date | N/A |
| Forward Dividend & Yield | 1.09 (1.58%) |
| Ex-Dividend Date | Mar 25, 2022 |
| 1y Target Est | N/A |
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Subscribe to Yahoo Finance Plus to view Fair Value for CHEOY
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
- COCHLEAR LTD UNSP ADR EACH REPAnalyst Report: Coloplast A/SColoplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy-care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and wound-care markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.RatingFair ValueEconomic Moat2 months agoMorningstar
- Simply Wall St.
Returns On Capital At Cochlear (ASX:COH) Paint A Concerning Picture
Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
- Simply Wall St.
What You Need To Know About Cochlear Limited's (ASX:COH) Investor Composition
A look at the shareholders of Cochlear Limited ( ASX:COH ) can tell us which group is most powerful. Generally...
- Simply Wall St.
Cochlear (ASX:COH) shareholders have earned a 9.2% CAGR over the last five years
When we invest, we're generally looking for stocks that outperform the market average. And the truth is, you can make...
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2022 Yahoo. All rights reserved.
